Enrofloxacin Chewable Tablets
• Flavored tablets for the treatment of bacterial infec-
tions of the urinary tract, prostate, liver, GI tract, and
other body systems
• Synthetic chemotherapeutic agent from the class of
quinolone carboxylic acid derivatives
• Antibacterial activity against a broad spectrum of
Gram negative and Gram positive bacteria
• Rapidly absorbed from the digestive tract,
penetrating into all measured body tissues and
fluids
• Available in 22.7mg, 68mg, and 136mg tablets
© 2020 Covetrus. All Rights Reserved. No copying without permission. Not responsible for typographical errors. Lit. No. 20CVB285 (09/2020)
855.724.3461
|
northamerica.covetrus.com
CONTRAINDICATIONS: The use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). The
safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. Consult package outsert for details.
WARNINGS: For use in animals only. In rare instances, use of this product in cats has been associated with retinal toxicity. Do not exceed 5 mg/kg of body weight per day in
cats. Safety in breeding or pregnant cats has not been established. Keep out of reach of children.
Comparable to Baytril
®
and Enroquin
TM
Flavored Tablets
Coming Soon!